Jilin Yatai Group

Jilin Yatai Group is a prominent Chinese conglomerate with a significant and diversified presence in the pharmaceutical and biotechnology sectors. The company's healthcare division focuses on the research, development, and large-scale manufacturing of vaccines, modern Traditional Chinese Medicine (TCM), and chemical drugs. Its flagship products include a widely utilized Rabies Vaccine (Vero Cell) and the anti-tumor medication Shenyi Capsule, which contains Ginsenoside Rg3. Headquartered in Changchun, the group leverages integrated R&D and GMP-certified production facilities to serve both domestic and international markets. In addition to healthcare, the group maintains interests in building materials, real estate, and energy, providing a stable financial foundation for its life sciences innovation.